合成路线1
该中间体在本合成路线中的序号:
(II) The condensation of 2-hydroxychloroacetophenone (I) with 4-chlorobenzaldehyde (II) by means of KOH in ethanol - water gives 4,5'-dichloro-2'-hydroxychalcone (III), which is cyclized by treatment with polyphosphoric acid (PPA) in reftuxing 2-methoxyethanol yielding 4',6-dichloroflavan (IV). Finally, this compound is reduced with Zn-Hg in acetic acid-hydrochloric acid.
【1】
Batchelor, J.F.; Bauer, D.J.; Hodson, H.F.; Selway, J.W.T.; Young, D.A.B. (Glaxo Wellcome plc); Flavans, process for their preparation and pharmaceutical compsns. containing them. EP 0004579 .
|
【2】
Serradell, M.N.; Castaner, J.; Hopkins, S.J.; Blancafort, P.; BW-683C. Drugs Fut 1982, 7, 8, 542.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
37094 |
1-(5-chloro-2-hydroxyphenyl)-1-ethanone
|
1450-74-4 |
C8H7ClO2 |
详情 | 详情
|
(II) |
29029 |
4-chlorobenzaldehyde
|
104-88-1 |
C7H5ClO |
详情 | 详情
|
(III) |
37095 |
(E)-1-(5-chloro-2-hydroxyphenyl)-3-(4-chlorophenyl)-2-propen-1-one
|
|
C15H10Cl2O2 |
详情 |
详情
|
(IV) |
37096 |
6-chloro-2-(4-chlorophenyl)-2,3-dihydro-4H-chromen-4-one
|
|
C15H10Cl2O2 |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(I) By reductocondensation of 4-chlorobenzaldehyde (I) with L-phenylalanine (II) by means of cyanoborohydride in methanol.
【1】
Ferres, H. (SmithKline Beecham plc); N-Substituted alpha-aminoacids, processes for making them and pharmaceutical compositions containing them. EP 0031653; ES 497907; JP 56092843 .
|
【2】
Castaner, J.; Serradell, M.N.; Thorpe, P.; BRL-26314. Drugs Fut 1985, 10, 1, 12.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
29029 |
4-chlorobenzaldehyde
|
104-88-1 |
C7H5ClO |
详情 | 详情
|
(II) |
13952 |
(S)-(-)-Phenylalanine; L-Phenylalanine
|
63-91-2 |
C9H11NO2 |
详情 | 详情
|
合成路线3
该中间体在本合成路线中的序号:
(X) This compound can be prepared in several different ways:
1) By reaction of p-chlorobenzoyl chloride (I) with N-(2-aminoethyl)morpholine (II) in pyridine.
2) By reaction of p-chlorobenzoyl anhydride (III) with N-(2-aminoethyl)morpholine (II) in pyridine.
3) By reaction of methyl p-chlorobenzoate (IV) with N-(2-aminoethyl)morpholine (II) at 120 C.
4) By reaction of N-(p-chlorobenzoyl)succinimide (V) with N-(2-aminoethyl)morpholine (II) in dioxane.
5) By reaction of p-nitrophenyl p-chlorobenzoate (VI) with N-(2-aminoethyl)morpholine (II) in THF.
6) By reaction of p-chloro-N-(2-chloroethyl)benzamide (VII) with morpholine (VIII) at 100 C.
7) By reaction of p-chlorobenzoylaziridine (IX) with morpholine (VIII) in refluxing toluene.
8) By reaction of p-chlorobenzaldehyde (X) with N-(2-aminoethyl)morpholine (II) in refluxing benzene to give 4-[2-[(p-chlorobenzylidene)amino]ethyl]morpholine (XI), followed by an oxidation with H2O2 in methanol.
9) By reaction of p-chloro-N-(2-morpholinoethyl)thiobenzamide (XII) with lead tetraacetate in refluxing water.
11) By reaction of p-chlorobenzoic acid (XIV) with N-(2-aminoethyl)morpholine (II) by means of dicyclohexylcarbodiimide in pyridine, or by means of chloroformic acid ethyl ester and triethylamine in acetone.
10) By isomerization of (alpha-(p-chlorophenyl)-N-(2-morpholinoethyl)nitrone (XIII) in hot acetic acid - acetic anhydride, followed by a treatment with NaOH.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10295 |
p-Chlorobenzoyl chloride; 4-Chlorobenzoyl chloride
|
122-01-0 |
C7H4Cl2O |
详情 | 详情
|
(II) |
12880 |
4-(2-Aminoethyl)morpholine; 2-(4-Morpholinyl)ethylamine; 2-(4-Morpholinyl)-1-ethanamine; N-(2-Aminoethyl)morpholine; N-Morpholine ethanamide
|
2038-03-1 |
C6H14N2O |
详情 | 详情
|
(III) |
30702 |
4-chloro-1-benzenecarboxylic anhydride
|
|
C14H8Cl2O3 |
详情 |
详情
|
(IV) |
30703 |
methyl 4-chlorobenzoate
|
1126-46-1 |
C8H7ClO2 |
详情 | 详情
|
(V) |
30704 |
1-(4-chlorobenzoyl)-2,5-pyrrolidinedione
|
|
C11H8ClNO3 |
详情 |
详情
|
(VI) |
30705 |
4-nitrophenyl 4-chlorobenzoate
|
|
C13H8ClNO4 |
详情 |
详情
|
(VII) |
30706 |
4-chloro-N-(2-chloroethyl)benzamide
|
|
C9H9Cl2NO |
详情 |
详情
|
(VIII) |
10388 |
Morpholine
|
110-91-8 |
C4H9NO |
详情 | 详情
|
(IX) |
30707 |
1-aziridinyl(4-chlorophenyl)methanone
|
|
C9H8ClNO |
详情 |
详情
|
(X) |
29029 |
4-chlorobenzaldehyde
|
104-88-1 |
C7H5ClO |
详情 | 详情
|
(XI) |
30708 |
N-[(E)-(4-chlorophenyl)methylidene]-2-(4-morpholinyl)-1-ethanamine; N-[(E)-(4-chlorophenyl)methylidene]-N-[2-(4-morpholinyl)ethyl]amine
|
|
C13H17ClN2O |
详情 |
详情
|
(XII) |
30709 |
4-chloro-N-[2-(4-morpholinyl)ethyl]benzenecarbothioamide
|
|
C13H17ClN2OS |
详情 |
详情
|
(XIII) |
30710 |
[(Z)-(4-chlorophenyl)methylidene][2-(4-morpholinyl)ethyl]ammoniumolate
|
|
C13H17ClN2O2 |
详情 |
详情
|
(XIV) |
18359 |
p-chlorobenzoic acid; 4-chlorobenzoic acid
|
74-11-3 |
C7H5ClO2 |
详情 | 详情
|
合成路线4
该中间体在本合成路线中的序号:
(I) The reaction of p-chlorobenzaldehyde (I) sodium cyanide and ethyl acetate gives ethyl 4-(p-chlorophenyl)-4-oxobutyrate (II), which is hydrolyzed with KOH to the corresponding free acid (III). The reduction of (III) with Zn and aqueous HCl affords 4-(p-chlorophenyl)butyric acid (IV), which is condensed with heptylamine (B) by means of oxalyl chloride (A) in refluxing benzene to yield N-heptyl-4-(p-chlorophenyl)butyramide (V), which is reduced with diborane in refluxing THF to afford N-heptyl-4-(p-chlorophenyl)butylamine (VI). The acetylation of (VI) with acetyl chloride (C) by means of Na2CO3 in acetone gives N-acetyl-N-heptyl-4-(p-chlorophenyl)butylamine (VII), which is reduced with diborane as before to yield N-ethyl-N-heptyl-4-(p-chlorophenyl)butylamine (VIII). The quaternization of (VIII) with refluxing ethyl bromide (D) gives N,N-diethyl-N-heptyl-4-(p-chlorophenyl)butylammonium bromide (IX), which by elution through a column with Dowex 1-X8, hydroxide form, resin is converted into N,N-diethyl-N-heptyl-4-(p-chlorophenyl)butyl ammonium hydroxide (X). Finally, this compound is salified with diluted aqueous phosphoric acid.
【1】
Molloy, B.B.; Steinberg, M.I.; EP 0002604 .
|
【2】
Hillier, K.; Castaner, J.; Clofilium Phosphate. Drugs Fut 1981, 6, 12, 764.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
23252 |
1-heptanamine; heptylamine
|
111-68-2 |
C7H17N |
详情 | 详情
|
(A) |
29841 |
Oxalyl chloride; 2-Chloro-2-oxoacetyl chloride
|
79-37-8 |
C2Cl2O2 |
详情 | 详情
|
(D) |
30344 |
1-bromoethane;ethyl bromide |
74-96-4 |
C2H5Br |
详情 | 详情
|
(I) |
29029 |
4-chlorobenzaldehyde
|
104-88-1 |
C7H5ClO |
详情 | 详情
|
(II) |
37460 |
ethyl 4-(4-chlorophenyl)-4-oxobutanoate
|
|
C12H13ClO3 |
详情 |
详情
|
(III) |
37461 |
4-(4-chlorophenyl)-4-oxobutyric acid
|
3984-34-7 |
C10H9ClO3 |
详情 | 详情
|
(IV) |
37462 |
4-(4-chlorophenyl)butyric acid
|
|
C10H11ClO2 |
详情 |
详情
|
(V) |
37463 |
4-(4-chlorophenyl)-N-heptylbutanamide
|
|
C17H26ClNO |
详情 |
详情
|
(VI) |
37464 |
N-[4-(4-chlorophenyl)butyl]-1-heptanamine; N-[4-(4-chlorophenyl)butyl]-N-heptylamine
|
|
C17H28ClN |
详情 |
详情
|
(VII) |
37465 |
N-[4-(4-chlorophenyl)butyl]-N-heptylacetamide
|
|
C19H30ClNO |
详情 |
详情
|
(VIII) |
37466 |
N-[4-(4-chlorophenyl)butyl]-N-ethyl-N-heptylamine; N-[4-(4-chlorophenyl)butyl]-N-ethyl-1-heptanamine
|
|
C19H32ClN |
详情 |
详情
|
(IX) |
37467 |
N-[4-(4-chlorophenyl)butyl]-N,N-diethyl-1-heptanaminium bromide
|
|
C21H37BrClN |
详情 |
详情
|
(X) |
37468 |
N-[4-(4-chlorophenyl)butyl]-N,N-diethyl-1-heptanaminium hydroxide
|
|
C21H38ClNO |
详情 |
详情
|
(C) |
19273 |
acetyl chloride
|
75-36-5 |
C2H3ClO |
详情 | 详情
|
合成路线5
该中间体在本合成路线中的序号:
(I) A new synthesis of FTY-720 has been reported: Condensation of 4-chlorobenzaldehyde (I) with octylzinc iodide (II) by means of Ni(0) gives 4-octylbenzaldehyde (III), which is treated with vinylmagnesium bromide (IV) to yield the allyl alcohol (V). Epoxidation of (V) with MCPBA affords the epoxide (VI), which is opened by means of NaNO2 and MgSO4 in refluxing methanol to provide 3-nitro-1-(4-octylphenyl)propane-1,2-diol (VII). Reaction of diol (VII) with trimethylsilyl chloride and NaI in acetonitrile gives 3-nitro-1-(4-octylphenyl)-1-propene (VIII), which is hydrogenated with H2 over Pd/C in ethanol yielding the corresponding nitropropane derivative (IX). The bis-formylation of compound (IX) with aqueous HCHO in the presence of Amberlyst A-21 in dichloromethane affords 2-nitro-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol (X), which is finally reduced with H2 over Ra-Ni to provide FTY-720.
【1】
Kalita, B.; Barua, N.C.; Bez, G; Bezbarua, M.; Synthesis of 2-nitro alcohols by regioselective ring opening of epoxides with MgSO4/NeOH/NaNO2 system: A short synthesis of immunosuppressive agent FTY-720. Synlett 2001, 9, 1411.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
29029 |
4-chlorobenzaldehyde
|
104-88-1 |
C7H5ClO |
详情 | 详情
|
(II) |
53249 |
iodo(octyl)zinc
|
n/a |
C8H17IZn |
详情 | 详情
|
(III) |
53250 |
4-Octylbenzaldehyde
|
49763-66-8 |
C15H22O |
详情 | 详情
|
(IV) |
16524 |
bromo(vinyl)magnesium
|
1826-67-1 |
C2H3BrMg |
详情 | 详情
|
(V) |
53251 |
1-(4-octylphenyl)-2-propen-1-ol
|
n/a |
C17H26O |
详情 | 详情
|
(VI) |
53252 |
(4-octylphenyl)(2-oxiranyl)methanol
|
n/a |
C17H26O2 |
详情 | 详情
|
(VII) |
53253 |
3-nitro-1-(4-octylphenyl)-1,2-propanediol
|
n/a |
C17H27NO4 |
详情 | 详情
|
(VIII) |
53254 |
1-[(E)-3-nitro-1-propenyl]-4-octylbenzene
|
n/a |
C17H25NO2 |
详情 | 详情
|
(IX) |
53255 |
1-(3-nitropropyl)-4-octylbenzene
|
n/a |
C17H27NO2 |
详情 | 详情
|
(X) |
53256 |
2-nitro-2-(4-octylphenethyl)-1,3-propanediol
|
n/a |
C19H31NO4 |
详情 | 详情
|
合成路线6
该中间体在本合成路线中的序号:
(III) Esterification of L-tryptophan (I) by means of MeOH and SOCl2 gave the corresponding methyl ester (II). Subsequent Pictet-Spengler cyclization of (II) with 4-chlorobenzaldehyde (III) furnished the tetrahydropyridoindole (IV), which was dehydrogenated to the beta-carboline (V) using sulfur in refluxing xylene. The ester group of (V) was finally reduced to the target alcohol with LiAlH4 in THF.
【1】
Srivastava, S.K.; et al.; Potent 1,3-disubstituted-9H-pyrido[3,4-b]indoles as new lead compounds in antifilarial chemotherapy. J Med Chem 1999, 42, 9, 1667.
|
【2】
Srivastava, S.K.; et al.; Potent 1,3-disubstituted-9H-pyrido[3,4-b]indoles as new lead compounds in antifilarial chemotherapy. Bioorg Med Chem 1999, 7, 6, 1223.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
30836 |
L-tryptophan
|
73-22-3 |
C11H12N2O2 |
详情 | 详情
|
(II) |
30837 |
methyl (2S)-2-amino-3-(1H-indol-3-yl)propanoate
|
|
C12H14N2O2 |
详情 |
详情
|
(III) |
29029 |
4-chlorobenzaldehyde
|
104-88-1 |
C7H5ClO |
详情 | 详情
|
(IV) |
30834 |
methyl 1-(4-chlorophenyl)-2,3,4,9-tetrahydro-1H-beta-carboline-3-carboxylate
|
|
C19H17ClN2O2 |
详情 |
详情
|
(V) |
30835 |
methyl 1-(4-chlorophenyl)-9H-beta-carboline-3-carboxylate
|
|
C19H13ClN2O2 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(IX) The reaction of 3,5-dihydroxybenzoic acid (I) with N,O-dimethylhydroxylamine (II) by means of EDC and NMM in dichloromethane gives the N,O-dimethylbenzamide (III), which is alkylated with butyl bromide (IV) and K2CO3 in hot DMF to yield the dibutoxybenzamide (V). The condensation of (V) with 4-methylpyridine (VI) by means of LDA in THF affords 1-(2,4-dibutoxyphenyl)-2-(4-pyridyl)ethanone (VII), which is oxidized with SeO2 in hot acetic acid to provide the dione (VIII). Finally, this compound is cyclized with 4-chlorobenzaldehyde (IX) and ammonium acetate in refluxing acetic acid to furnish the target imidazole.
【1】
Chang, L.L.; et al.; Substituted imidazoles as gluagon receptor antagonists. Bioorg Med Chem Lett 2001, 11, 18, 2549.
|
【2】
de Laszlo, S.; O'Keefe, S.; Li, B.; MacCoss, M.; Rolando, A.; mantlo, N.; Koch, G.; Cascieri, M.A.; Hagmann, W.K.; Chang, L.L.; Pang, M.; Sidler, K.L.; Selective, non-peptide antagonists for the glucagon receptor: Substituted imidazoles. 221st ACS Natl Meet (April 1 2001, San Diego) 2001, Abst MEDI 237. |
【3】
Chang, L.L. (Merck & Co., Inc.); Triaryl substd. imidazoles as glucagon antagonists. EP 0959886; JP 2000514088; US 5880139; WO 9822109 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
48820 |
2,4-Dihydroxybenzenecarboxylic acid; 2,4-Dihydroxybenzoic acid; beta-Resorcylic acid; Resorcinol-4-carboxylic acid
|
89-86-1 |
C7H6O4 |
详情 | 详情
|
(II) |
13361 |
(Methoxyamino)methane; N,O-Dimethylhydroxylamine
|
1117-97-1 |
C2H7NO |
详情 | 详情
|
(III) |
48821 |
2,4-dihydroxy-N-methoxy-N-methylbenzamide
|
|
C9H11NO4 |
详情 |
详情
|
(IV) |
28721 |
1-bromobutane
|
109-65-9 |
C4H9Br |
详情 | 详情
|
(V) |
48822 |
2,4-dibutoxy-N-methoxy-N-methylbenzamide
|
|
C17H27NO4 |
详情 |
详情
|
(VI) |
31150 |
4-methylpyridine
|
108-89-4 |
C6H7N |
详情 | 详情
|
(VII) |
48823 |
1-(2,4-dibutoxyphenyl)-2-(4-pyridinyl)-1-ethanone
|
|
C21H27NO3 |
详情 |
详情
|
(VIII) |
48824 |
1-(2,4-dibutoxyphenyl)-2-(4-pyridinyl)-1,2-ethanedione
|
|
C21H25NO4 |
详情 |
详情
|
(IX) |
29029 |
4-chlorobenzaldehyde
|
104-88-1 |
C7H5ClO |
详情 | 详情
|
合成路线8
该中间体在本合成路线中的序号:
(I) The beta-amino acid (II) was prepared by Knoevenagel condensation of 4-chlorobenzaldehyde (I) with malonic acid in the presence of ammonium acetate. After protection of the amino group of (II) with Fmoc-Cl, the protected amino acid (III) was attached to the trityl chloride polystyrol resin, yielding the amino acid-bound resin (IV). The Fmoc group of (IV) was then removed using piperidine in DMF to afford (V). N-Fmoc-hydrazine (VI) was carbonylated with phosgene to obtain the oxadiazolone (VII). This was condensed with the amino resin (V) producing adduct (VIII). Deprotection of the Fmoc group of (VIII), followed by coupling with N-Fmoc-3-aminobenzoic acid (IX), furnished (X). After a new deprotection of (X) with piperidine in DMF, the guanidino group was introduced by condensation with N,N'-bis-Boc-1-guanylpyrazole to give (XI). Finally, deprotection and cleavage of the resin adduct (XI) was carried out with trifluoroacetic acid in the presence of triisopropylsilane.
【1】
Sulyok, G.A.G.; et al.; Solid-phase synthesis of a nonpeptide RGD mimetic library: New selective alphavbeta3 integrin antagonists. J Med Chem 2001, 44, 12, 1938.
|
【2】
Sulyok, G.; Kessler, H.; Holzemann, G.; Goodman, S.; Gibson, C. (Merck Patent GmbH); Diacylhydrazine derivs.. DE 19932796; WO 0105753 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(II),(V) |
49780 |
3-Amino-3-(4-chlorophenyl)propionic acid
|
|
C9H10ClNO2 |
详情 |
详情
|
(III),(IV) |
49781 |
3-(4-chlorophenyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-beta-alanine
|
|
C24H20ClNO4 |
详情 |
详情
|
(I) |
29029 |
4-chlorobenzaldehyde
|
104-88-1 |
C7H5ClO |
详情 | 详情
|
(VI) |
49782 |
9-Fluorenylmethyl carbazate; Fmoc-hydrazide
|
35661-51-9 |
C15H14N2O2 |
详情 | 详情
|
(VII) |
49783 |
5-(9H-fluoren-9-ylmethoxy)-1,3,4-oxadiazol-2(3H)-one
|
|
C16H12N2O3 |
详情 |
详情
|
(VIII) |
49784 |
3-(4-chlorophenyl)-N-([2-[(9H-fluoren-9-ylmethoxy)carbonyl]hydrazino]carbonyl)-beta-alanine
|
|
C25H22ClN3O5 |
详情 |
详情
|
(IX) |
49785 |
3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]benzoic acid
|
|
C22H17NO4 |
详情 |
详情
|
(X) |
49786 |
3-(4-chlorophenyl)-N-[[2-(3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]benzoyl)hydrazino]carbonyl]-beta-alanine
|
|
C32H27ClN4O6 |
详情 |
详情
|
(XI) |
49787 |
N-([2-[3-([[(tert-butoxycarbonyl)amino][(tert-butoxycarbonyl)imino]methyl]amino)benzoyl]hydrazino]carbonyl)-3-(4-chlorophenyl)-beta-alanine
|
|
C28H35ClN6O8 |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(II) Condensation between 2-(3,4-dimethoxyphenyl)ethylamine (I) and 4-chlorobenzaldehyde (II) in refluxing toluene affords imine (III). Then, Pictet-Spengler cyclization of imine (III) in the presence of trifluoroacetic acid leads to the tetrahydroisoquinoline (IV). This is further acylated in boiling acetic anhydride to produce the target acetamide.
【1】
Gitto, A.; Barreca, M.L.; De Luca, L.; De Sarro, G.; Ferreri, G.; Quartarone, S.; Russo, E.; Constanti, A.; Chimirri, A.; Discovery of a novel and highly potent noncompetitive AMPA receptor antagonist. J Med Chem 2003, 46, 1, 197.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10098 |
2-(3,4-Dimethoxyphenyl)-1-ethanamine; 3,4-Dimethoxyphenethylamine; 2-(3,4-Dimethoxyphenyl)ethylamine
|
120-20-7 |
C10H15NO2 |
详情 | 详情
|
(II) |
29029 |
4-chlorobenzaldehyde
|
104-88-1 |
C7H5ClO |
详情 | 详情
|
(III) |
65051 |
N-[(E)-(4-chlorophenyl)methylidene]-2-(3,4-dimethoxyphenyl)-1-ethanamine; N-[(E)-(4-chlorophenyl)methylidene]-N-(3,4-dimethoxyphenethyl)amine
|
|
C17H18ClNO2 |
详情 |
详情
|
(IV) |
65052 |
1-(4-chlorophenyl)-6-methoxy-1,2,3,4-tetrahydro-7-isoquinolinyl methyl ether; 1-(4-chlorophenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline
|
|
C17H18ClNO2 |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(VII)
【1】
Murugesan B, Rafe M, Sathyananarayana S(Ranbaxy Laboratories Limited, India). 2007. A process for the preparation of dichlorofluorene as a key intermediate to lumefantrine. Indian Pat Appl, IN 2007DE00012. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
67236 |
Fluorene;Diphenylenemethane;2,2'-Methylenebiphenyl;2,3-Benzindene;o-Biphenylenemethane;alpha-Diphenylenemethane-9H-fluorene |
86-73-7 |
C13H10 |
详情 | 详情
|
(III) |
67237 |
2,7-dichloro-9H-fluorene |
7012-16-0 |
C13H8Cl2 |
详情 | 详情
|
(IV) |
67240 |
2-(2,7-dichloro-9H-fluoren-4-yl)oxirane |
53221-14-0 |
C15H10Cl2O |
详情 | 详情
|
(V) |
33492 |
N,N-dibutylamine; N-butyl-1-butanamine
|
111-92-2 |
C8H19N |
详情 | 详情
|
(VI) |
67241 |
2-(dibutylamino)-1-(2,7-dichloro-9H-fluoren-4-yl)ethanol |
69759-61-1 |
C23H29Cl2NO |
详情 | 详情
|
(VII) |
29029 |
4-chlorobenzaldehyde
|
104-88-1 |
C7H5ClO |
详情 | 详情
|
(IX) |
67246 |
sulfuryl dichloride |
7791-25-5 |
Cl2O2S |
详情 | 详情
|
合成路线11
该中间体在本合成路线中的序号:
(XIII) Intermediate (XIb) is prepared by condensation of 4-chlorobenzaldehyde (XIII) with NH4OH and (S)-(+)-epichlorohydrin (XIV) in MTBE or MeOH to yield imine (XV). Then imine (XV) is condensed with carbamate (VI) using t-BuOLi to give the 2-oxazolidinone derivative (XVI), which is finally hydrolyzed with HCl in EtOAc/H2O .
【1】
Brickner, S.J., Nuermberger, E., Stover, C.K. (Pfizer, Inc.). Combination therapy for tuberculosis. CN 102143748, EP 2340022, JP 20122502017, KR 2011063518, US 2011190199, WO 2010026526. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XIb) |
68067 |
(R)-5-(aminomethyl)-3-(3-fluoro-4-thiomorpholinophenyl)oxazolidin-2-one hydrochloride |
|
C14H18FN3O2S.HCl |
详情 | 详情
|
(VI) |
68062 |
benzyl (3-fluoro-4-thiomorpholinophenyl)carbamate |
|
C18H19FN2O2S |
详情 | 详情
|
(XIII) |
29029 |
4-chlorobenzaldehyde
|
104-88-1 |
C7H5ClO |
详情 | 详情
|
(XIV) |
13917 |
(S)-Epichlorohydrin; (2S)-2-(Chloromethyl)oxirane;(S)-(+)-epichlorohydrin |
67843-74-7 |
C3H5ClO |
详情 | 详情
|
(XV) |
68068 |
(R,E)-1-chloro-3-((4-chlorobenzylidene)amino)propan-2-ol |
|
C10H11Cl2NO |
详情 | 详情
|
(XVI) |
68069 |
(R,E)-5-(((4-chlorobenzylidene)amino)methyl)-3-(3-fluoro-4-thiomorpholinophenyl)oxazolidin-2-one |
|
C21H21ClFN3O2S |
详情 | 详情
|